| Literature DB >> 3581712 |
A G Fennerty, J Dolben, P Thomas, G Backhouse, D P Bentley, I A Campbell, P A Routledge.
Abstract
One hundred hospital in-patients treated for pulmonary embolism (PE) and/or deep vein thrombosis (DVT) were randomly allocated to receive 3 or 6 weeks' anticoagulation with heparin and warfarin. At one year recurrence rates were 12% in the 6 week group and 10% in those treated for 3 weeks. No patient died as a result of recurrence. Our study suggests that 3 weeks' anticoagulation therapy, using intravenous heparin for the first 5 days and warfarin from the third day, is adequate for patients without persisting risk factors.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3581712 DOI： 10.1111/j.1365-2257.1987.tb01377.x
Source DB: PubMed Journal: Clin Lab Haematol ISSN： 0141-9854